Concepedia

Jiri Hardlund

JH

Statistics

Publications

3

Citations

668

H-Index

3

Active since

2016

Affiliations

TauRx (United Kingdom)(Current)

University of Aberdeen

Douglas Mental Health University Institute

University of Cambridge

University of Oxford

Jiri Hardlund is an author at TauRx (United Kingdom) specializing in pharmacology, dementia, and medicine.

Publications per year

2016–2020

3

Publications

3

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Serge Gauthier, Howard Feldman, Lon S. Schneider et al. · The Lancet · 2016 · 416 citations · Full text

Medicine, Neurology, Pharmacology +14

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni et al. · Journal of Alzheimer s Disease · 2017 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

Helen Shiells, B. Schelter, Peter Bentham et al. · Journal of Alzheimer s Disease · 2020 · 35 citations · Full text

Medicine, Neurology, Pharmacology +17

1–3 of 3